Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma.

Hoshimoto S, Faries MB, Morton DL, Shingai T, Kuo C, Wang HJ, Elashoff R, Mozzillo N, Kelley MC, Thompson JF, Lee JE, Hoon DS
Ann Surg. 2012 255 (2): 357-62

PMID: 22202581 · PMCID: PMC3320770 · DOI:10.1097/SLA.0b013e3182380f56

MeSH Terms (24)

Adult Aged Antigens, Neoplasm Biomarkers, Tumor Cancer Vaccines Chemotherapy, Adjuvant Double-Blind Method Female Humans Male MART-1 Antigen Melanoma Middle Aged Multivariate Analysis Neoplasm Proteins Neoplasm Staging Neoplastic Cells, Circulating Paired Box Transcription Factors PAX3 Transcription Factor Prognosis Real-Time Polymerase Chain Reaction Recurrence Reverse Transcriptase Polymerase Chain Reaction Survival Analysis

Connections (1)

This publication is referenced by other Labnodes entities: